newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Genetic Metabolic Dieticians International Conference

NEWTON, Mass. and GENEVA, May 06, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER) ("Acer") and its collaboration partner, Relief Therapeutics Holding SA ((SIX: RLF, OTCQB:RLFTF, RLFTY)) ("Relief"), today announced the presentation of data